Is HBOT better than red light therapy?

Not on anything both reports score. Red light therapy is 8.0 against HBOT's 6.2, and across 34 shared use cases HBOT does not win one, tying only on cognition (6.5 against 6.4) and cellular senescence (5.8 against 5.7). HBOT's genuine advantages are medical indications red light does not score at all, such as decompression sickness and refractory osteomyelitis.

Can I skip HBOT and just buy a red light panel?

For skin, hair, joint pain, exercise recovery and mitochondrial support, yes. Those are the rows red light wins outright and it costs about 1% as much. The exception is a named medical indication. A diabetic foot ulcer, delayed radiation injury or carbon monoxide poisoning belongs in a chamber under medical care, and no panel substitutes for that.

How much does HBOT actually cost?

$3,000 to $6,000 a month at the protocol dose, extracted from the source report and priced 2026-09-07. That is five 90-minute sessions a week at $150 to $300 each, before diagnostics and travel. The cognitive-aging protocol in Hadanny 2020 ran 60 sessions, so budget three months.

Are home hyperbaric chambers worth it?

Not for the reasons they are sold. Soft chambers run at 1.3 to 1.5 ATA and every result people cite for cognition, fibromyalgia and post-stroke recovery comes from hard chambers at 2.0 to 2.4 ATA. Buying a soft chamber buys a different intervention with its own thin evidence, at a price where a verified red light panel has trials at the dose you will use.

Does HBOT help long COVID?

The best-designed trial says no. HOT-LoCO (Kjellberg 2025) randomised 80 people to 10 sessions or sham and found no advantage at 13 weeks on RAND-36 physical functioning or role-physical. Longer-course follow-up data exists (Hadanny 2024) but is not the sham-controlled result. Treat post-viral claims with heavy skepticism.

Red light, clearly. It scores 1.4 on safety risk and 1.3 on side effects against HBOT's 3.6 and 2.8. HBOT is contraindicated with untreated pneumothorax, COPD with bullae, uncontrolled seizure disorder, inability to equalise the ears and during bleomycin, cisplatin or doxorubicin chemotherapy. Red light's exclusions are local: melanoma in the field, photosensitising drugs, porphyria, and eye protection at high irradiance.

How long until either one works?

Red light gives a first noticeable change around 2 weeks, has a 12-week assessment window and keeps improving to about 24 weeks. HBOT's first change is estimated at 4 weeks with full effect at 12, but that assumes the clinic protocol of five sessions a week. Judge red light at 12 weeks, not at 2.

How do I know my red light panel is strong enough?

Measure irradiance at the distance you actually treat from, usually 6 to 12 inches. The source report is explicit that advertised output is often inflated, so the spec sheet is not evidence. Follow the WALT dosing standards for your indication. An underpowered panel produces a null result that people misread as the modality failing.

Nothing about the mechanisms conflicts. They share exactly one target, VEGF, and nothing upstream: HBOT works through dissolved plasma oxygen and the hyperoxic-hypoxic paradox, red light through cytochrome c oxidase and nitric oxide release. No trial in either report combined them, so any synergy claim is speculation.

Head-to-Head Comparison

HBOT vs Red Light Therapy: Which Is Better for Recovery?

Should I spend on HBOT or a red light panel?

Reviewed 09/08/2026

Buy the panel. Red light therapy scores 8.0 against HBOT's 6.2, costs $17 to $43 a month against $3,000 to $6,000, and does not lose a single use case both reports score. HBOT earns its price only for a named medical indication, which is a doctor's decision rather than a recovery purchase.

Red light therapy 8.0, HBOT 6.2. Across the 34 use cases both reports score, HBOT does not win one.
The cost gap is roughly 100 to 1: $17 to $43 a month amortised for a panel against $3,000 to $6,000 a month for 20 hard-chamber sessions.
HBOT's real case is medical, not recreational. The UHMS list, and Lin 2023 in Cochrane for late radiation tissue injury, are indication-specific.
The long COVID claim is dead. HOT-LoCO (Kjellberg 2025) randomised 80 people and found 10 sessions no better than sham at 13 weeks.
Soft home chambers at 1.3 to 1.5 ATA are not the intervention that produced the evidence. Hadanny 2020 ran 60 sessions at 2.0 ATA.
Red light's own weak spots are real: Pradal 2025 was null for burn-wound retraction and collagen deposition.
Panels lie about output. The gate is verified irradiance at a real treatment distance, not the number on the box.
Safety is not close either. Red light scores 1.4 on safety risk against HBOT's 3.6, and HBOT's contraindication list includes untreated pneumothorax and chemotherapy agents.

At a Glance

Option A

Hyperbaric Oxygen Therapy

6.2 / 10 Worth trying

Upside

Efficacy 4.4
Breadth 4.5
Evidence 4.4
Speed 3.4
Durability 3.8
Bioindividuality 4.0

Downside

Safety Risk 3.6
Side Effects 2.8
Cost 4.7
Effort 4.6
Opportunity Cost 3.4
Dependency 1.5
Reversibility 1.6

Best at:

Wound Healing 7.8
Hearing Auditory 6.8
Injury Recovery 6.5
Bone Joint 6.4

Hard-chamber hyperbaric oxygen at 2.0 ATA, clinic-delivered. BioHarmony 6.2, worth trying.

Read full BioHarmony report →

Head-to-Head Verdict

Use Case	Winner	Rationale
Wound Healing	Tie	Red light 8.3 against HBOT 7.8, and this is the one row where the subratings and the trial evidence pull apart. For hard-to-heal clinical wounds HBOT is the better answer: Yang 2024 pooled 15 studies showing better healing when hyperbaric oxygen was added to negative-pressure wound therapy, and Lin 2023 is a Cochrane review supporting late radiation tissue injury.Red light's wound data is superficial and partly negative, with Pradal 2025 null for burn-wound retraction and collagen deposition. Split it by wound: a diabetic foot ulcer belongs in a chamber, a healing incision does not.
Skin Beauty	Red Light Therapy	Red light 8.2 against 4.6, the widest gap after hair. Wunsch 2014 ran 113 people through 30 sessions and reported wrinkle reduction and increased intradermal collagen density. HBOT has no dedicated cosmetic dermatology trial in its evidence list. If skin is why you are shopping, this row ends the comparison on its own.
Hair Nail	Red Light Therapy	Red light 8.0 against HBOT's 1.4. Lanzafame 2013 randomised 44 people over 16 weeks and found a 35% hair-count increase against 2% on sham. HBOT scores near the floor because nothing in its literature touches this.
Mitochondrial	Red Light Therapy	Red light 8.5 against 5.6. This is red light's home ground: Karu 2010 identified cytochrome c oxidase as the photoacceptor and Hamblin 2017 mapped the downstream anti-inflammatory signaling. HBOT touches mitochondria too, through the hyperoxic-hypoxic paradox and HIF-1a, but indirectly and at 100 times the price.
Injury Recovery	Red Light Therapy	Red light 7.8 against 6.5. Leal-Junior 2015 pooled 13 RCTs in roughly 650 people and found a positive effect on muscle performance with a delayed-onset soreness effect size of 0.45.Lawrence 2024 is more measured, calling it promising for surface wound healing and localised exercise recovery and less convincing for deep-tissue injury. HBOT's own recovery evidence sits mostly in clinical rehabilitation populations.
Chronic Pain	Red Light Therapy	Red light 7.0 against 5.7. Fan 2024 pooled 13 RCTs in 673 people with knee osteoarthritis and found a pain effect size of 0.96, with the caveat that certainty was low to very low. HBOT's pain case is Efrati 2015 in fibromyalgia, a prospective crossover trial rather than a sham-controlled RCT, in a narrower population.
Bone Joint	Red Light Therapy	Red light 7.2 against 6.4, on the same Fan 2024 knee osteoarthritis data and the WALT dosing standards behind it. HBOT scores respectably here because refractory osteomyelitis is a UHMS-accepted indication, which is a hospital problem rather than a stiff-knee problem.
Cognition Focus	Tie	Red light 6.5 against HBOT 6.4, which is a rounding difference and should be read as even. Both have real signals and neither has a clean one. Hadanny 2020 randomised healthy older adults through 60 hard-chamber sessions at 2.0 ATA with cognitive gains.Transcranial red light has Naeser 2011, an open-label pilot in chronic mild TBI. An open-label pilot and a 60-session chamber course are not comparable commitments.
Cellular Senescence	Tie	Red light 5.8, HBOT 5.7. A tenth of a point apart, and both numbers are mid-scale for good reason. HBOT's entry here is Hachmo 2020, a telomere length and immunosenescence signal that its own report flags as under-replicated and methodologically contested. Neither belongs in a longevity plan on this evidence.

Cost Comparison

Intervention	Monthly Cost	Notes
HBOT (hard chamber)	$3,000 to $6,000	Extracted from the source report, priced 2026-09-07, clinic session channel. Hard-chamber sessions run $150 to $300 each, and the cognitive protocol is 2.0 ATA for 90 minutes with air breaks, five times a week, which is about 20 sessions a month. Diagnostics and travel are on top. This is the price of the protocol that generated the evidence, not the price of sitting in a soft chamber at home.
Red light therapy (home panel)	$17 to $43	ESTIMATE, priced 2026-09-07, one-time hardware amortised. A serious home panel is $1,000 to $2,500, which over five years is $17 to $42 a month plus about $1 of electricity. Clinic sessions at $30 to $60 each are the alternative and cost more over any real course.
The difference	Roughly 100 to 1	A single month of the hard-chamber protocol costs more than two top-end panels. Put differently, the entire five-year cost of owning a panel is about one week of HBOT at five sessions a week.That ratio only matters if the two do similar things, and across the 34 use cases both reports score, HBOT does not win one. The chamber earns its price when the indication is medical and named. It does not earn it as a recovery upgrade.

When to Switch

These run on different clocks and different commitments. Red light gives a first noticeable change at about 2 weeks, a 12-week assessment window and full effect out at 24 weeks, on 10 to 20 minutes a day at home.

HBOT's first noticeable change is estimated at 4 weeks with full effect at 12, but only because the protocol behind it is 90-minute clinic sessions five times a week. One is a habit. The other is most of a workday every week.

Start with the panel in every case where the target is skin, hair, joint pain, exercise recovery or general mitochondrial support. Red light wins or ties all of those and costs about 1% as much. Give it the full 12 weeks before judging, because 2 weeks tells you almost nothing at these effect sizes, and verify the irradiance you are actually delivering before you conclude it did not work.

Move to HBOT only when a named indication appears, and let a clinician name it. The Undersea and Hyperbaric Medical Society list is the reference: decompression sickness, carbon monoxide poisoning, arterial gas embolism, selected diabetic foot ulcers, delayed radiation injury, refractory osteomyelitis, compromised grafts and flaps, sudden sensorineural hearing loss.

Off-label, the defensible case is an older adult with documented cognitive complaints who can fund 60 sessions at 2.0 ATA, which is the Hadanny 2020 protocol rather than a shorter course.

Do not switch to HBOT for long COVID or post-viral fatigue. HOT-LoCO (Kjellberg 2025) randomised 80 people and found 10 sessions no better than sham at 13 weeks on physical functioning. Running both is possible and untested: they share exactly one target, VEGF, and nothing upstream of it, so there is no interaction to fear and no synergy trial to point at either.

Who Should Pick What?

You want one recovery purchase and have a normal budget

Red Light Therapy

The panel, without hesitation. 8.0 against 6.2 overall, no lost use case across 34 shared rows, and $17 to $43 a month against $3,000 to $6,000. Spend the difference on sleep and training, which will outperform both.

Visible skin aging or early androgenetic alopecia

Red Light Therapy

Skin 8.2 against 4.6 and hair 8.0 against 1.4. Wunsch 2014 showed wrinkle and collagen-density improvement over 30 sessions, and Lanzafame 2013 showed a 35% hair-count increase against 2% sham over 16 weeks. HBOT has nothing to offer either endpoint.

Diabetic foot ulcer or delayed radiation injury under medical care

Hyperbaric Oxygen Therapy

This is what hyperbaric oxygen is actually for. Both are UHMS-accepted indications, Lin 2023 is a Cochrane review for late radiation tissue injury, and Yang 2024 showed better healing when HBOT was added to negative-pressure therapy. Red light's burn-wound data (Pradal 2025) was null. Do this through a clinic, not a purchase.

Older adult with documented cognitive complaints and real budget

Hyperbaric Oxygen Therapy

The one off-label case that survives scrutiny, and only at the right dose. Hadanny 2020 randomised healthy older adults through 60 sessions at 2.0 ATA. A ten-session package or a 1.3 ATA home chamber is not that protocol. Budget $3,000 to $6,000 a month for three months before starting.

Knee osteoarthritis or a chronic tendon problem

Red Light Therapy

Chronic pain 7.0 against 5.7 and bone-joint 7.2 against 6.4. Fan 2024 pooled 13 RCTs in 673 knee patients with a pain effect size of 0.96, though certainty was low. Follow the WALT dosing standards for your indication rather than guessing at time and distance.

Long COVID or post-viral fatigue

Red Light Therapy

Not because red light is proven here, but because HBOT was tested and failed. HOT-LoCO (Kjellberg 2025) found 10 sessions no better than sham at 13 weeks in 80 people. Spending $3,000 a month against that result is the clearest bad buy in this comparison.

Untreated pneumothorax, COPD with bullae, or uncontrolled seizures

Red Light Therapy

HBOT is contraindicated, not merely inadvisable, and the same applies during bleomycin, cisplatin or doxorubicin chemotherapy, with an uncontrolled fever, or if you cannot equalise your ears. Red light's exclusions are narrower: melanoma or a suspicious pigmented lesion in the field, photosensitising medication, porphyria or lupus photosensitivity.

Considering a 1.3 ATA soft chamber for the house

Red Light Therapy

Buy the panel instead. A soft chamber does not reproduce the 2.0 ATA protocols behind the cognition, fibromyalgia and post-stroke results, so the evidence you read about does not transfer to the thing you bought. For similar money, a verified panel has trials at the dose you will actually use.

Research Highlights

Mechanism Difference
These two overlap at exactly one target and nowhere upstream of it. HBOT pressurises 100% oxygen so plasma carries far more than haemoglobin can, and the repeated hyperoxia-then-normoxia swing triggers HIF-1a, VEGF-driven angiogenesis and CD34+ stem-cell mobilisation.Red light works by photon absorption at cytochrome c oxidase, releasing nitric oxide from complex IV, raising ATP and modulating reactive oxygen species. VEGF appears on both target lists. Pressure and photons are not substitutes, which is why running both creates no interaction worth fearing and no synergy anyone has trialled.
Cost Comparison
A month of hard-chamber HBOT at the protocol dose is $3,000 to $6,000: five sessions a week at $150 to $300 each, extracted from the source report and priced 2026-09-07. A serious red light panel is $1,000 to $2,500 once, which amortises to $17 to $43 a month over five years plus about a dollar of electricity.That is roughly 100 to 1. The whole five-year cost of owning a panel is about one week of HBOT. Across the 34 use cases both reports score, HBOT does not win one, so the ratio is not buying anything on those rows.
Editorial Verdict
Red light therapy scores 8.0 and HBOT 6.2, and the use-case rows agree with the headline for once. Red light wins skin, hair, mitochondrial signaling, injury recovery, chronic pain and bone-joint outright, and ties cognition and cellular senescence. Wound healing splits by wound type.HBOT's genuine wins sit outside this comparison entirely, in indications red light does not score at all: decompression sickness, carbon monoxide poisoning, arterial gas embolism, refractory osteomyelitis. Those are hospital decisions. As a purchase, the panel wins.
Safety Comparison
Red light scores 1.4 on safety risk and 1.3 on side effects. HBOT scores 3.6 and 2.8. That gap is structural rather than incidental: pressure has failure modes a lamp does not, and the source report's contraindication list names untreated pneumothorax, COPD with bullae, uncontrolled seizure disorder, inability to equalise the ears, and concurrent bleomycin, cisplatin or doxorubicin.Red light's exclusions are field-specific: active melanoma or a suspicious pigmented lesion in the treatment area, photosensitising medication such as isotretinoin or tetracyclines, porphyria or lupus photosensitivity, direct uterine exposure in pregnancy, and never at high irradiance without eye protection.
Dose Fidelity
Both interventions are commonly bought in a form that does not match their evidence. HBOT's cognitive, fibromyalgia and post-stroke results come from hard chambers at 2.0 to 2.4 ATA, typically over 40 to 60 sessions. Home soft chambers at 1.3 to 1.5 ATA are a different pressure tier and a different intervention.Red light's failure mode is advertised irradiance. The source report's access note is explicit that output claims are often inflated, so the gate is measured irradiance at 6 to 12 inches. A panel that underdelivers at your real treatment distance produces a null result you will misread as photobiomodulation not working.

Frequently Asked Questions

Is HBOT better than red light therapy?: Not on anything both reports score. Red light therapy is 8.0 against HBOT's 6.2, and across 34 shared use cases HBOT does not win one, tying only on cognition (6.5 against 6.4) and cellular senescence (5.8 against 5.7). HBOT's genuine advantages are medical indications red light does not score at all, such as decompression sickness and refractory osteomyelitis.
Can I skip HBOT and just buy a red light panel?: For skin, hair, joint pain, exercise recovery and mitochondrial support, yes. Those are the rows red light wins outright and it costs about 1% as much. The exception is a named medical indication. A diabetic foot ulcer, delayed radiation injury or carbon monoxide poisoning belongs in a chamber under medical care, and no panel substitutes for that.
How much does HBOT actually cost?: $3,000 to $6,000 a month at the protocol dose, extracted from the source report and priced 2026-09-07. That is five 90-minute sessions a week at $150 to $300 each, before diagnostics and travel. The cognitive-aging protocol in Hadanny 2020 ran 60 sessions, so budget three months.
Are home hyperbaric chambers worth it?: Not for the reasons they are sold. Soft chambers run at 1.3 to 1.5 ATA and every result people cite for cognition, fibromyalgia and post-stroke recovery comes from hard chambers at 2.0 to 2.4 ATA. Buying a soft chamber buys a different intervention with its own thin evidence, at a price where a verified red light panel has trials at the dose you will use.
Does HBOT help long COVID?: The best-designed trial says no. HOT-LoCO (Kjellberg 2025) randomised 80 people to 10 sessions or sham and found no advantage at 13 weeks on RAND-36 physical functioning or role-physical. Longer-course follow-up data exists (Hadanny 2024) but is not the sham-controlled result. Treat post-viral claims with heavy skepticism.
Which is safer?: Red light, clearly. It scores 1.4 on safety risk and 1.3 on side effects against HBOT's 3.6 and 2.8. HBOT is contraindicated with untreated pneumothorax, COPD with bullae, uncontrolled seizure disorder, inability to equalise the ears and during bleomycin, cisplatin or doxorubicin chemotherapy.Red light's exclusions are local: melanoma in the field, photosensitising drugs, porphyria, and eye protection at high irradiance.
How long until either one works?: Red light gives a first noticeable change around 2 weeks, has a 12-week assessment window and keeps improving to about 24 weeks. HBOT's first change is estimated at 4 weeks with full effect at 12, but that assumes the clinic protocol of five sessions a week. Judge red light at 12 weeks, not at 2.
How do I know my red light panel is strong enough?: Measure irradiance at the distance you actually treat from, usually 6 to 12 inches. The source report is explicit that advertised output is often inflated, so the spec sheet is not evidence. Follow the WALT dosing standards for your indication. An underpowered panel produces a null result that people misread as the modality failing.
Can I do both?: Nothing about the mechanisms conflicts. They share exactly one target, VEGF, and nothing upstream: HBOT works through dissolved plasma oxygen and the hyperoxic-hypoxic paradox, red light through cytochrome c oxidase and nitric oxide release. No trial in either report combined them, so any synergy claim is speculation.

Evidence Sources

RCT Ten sessions of hyperbaric oxygen versus sham in long COVID (HOT-LoCO) (2025) 80 randomised. Ten sessions were not superior to sham at 13 weeks on RAND-36 physical functioning or role-physical. Harms broadly similar.
Systematic review Adjunctive hyperbaric oxygen and negative pressure wound therapy for hard-to-heal wounds (2024) 15 studies. Negative-pressure therapy plus HBOT associated with a better wound-healing rate than negative-pressure therapy alone.
Systematic review Hyperbaric oxygen therapy for late radiation tissue injury, Cochrane Database of Systematic Reviews (2023) Indication-specific support for late radiation tissue injury rather than broad wellness use.
RCT Cognitive enhancement of healthy older adults using hyperbaric oxygen: a randomized controlled trial (2020) Older-adult cognitive-aging RCT using a hard-chamber 2.0 ATA, 60-session protocol.
Trial Hyperbaric oxygen therapy can diminish fibromyalgia syndrome, prospective clinical trial (2015) Prospective active-control crossover. Favourable direction for fibromyalgia symptoms, quality of life and brain SPECT activity.
Trial Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells (2020) Telomere and senescent-cell signal. Treated by the source report as under-replicated and methodologically contested.
Guideline Undersea and Hyperbaric Medical Society indications and practice standards (2026) Authority source for accepted clinical indications and facility standards.
Regulatory Hyperbaric oxygen therapy: don't be misled (2026) Distinguishes cleared uses from promoted unapproved uses and flags safety concerns.
Systematic review Adverse effects of hyperbaric oxygen therapy: systematic review (2023) Ear barotrauma, pressure threshold effects and pressure-related risk patterns.
RCT Effect of low-level laser therapy on androgenetic alopecia, randomized controlled trial (2013) 44 participants over 16 weeks. 35% hair-count increase against 2% on sham.
RCT Red and near-infrared light treatment for fine lines, wrinkles, skin roughness and intradermal collagen density (2014) 113 participants. Wrinkle reduction and collagen-density improvement at 30 sessions.
Meta-analysis Effect of phototherapy on exercise performance and markers of exercise recovery, meta-analysis (2015) 13 RCTs, about 650 people. Positive effect on muscle performance, delayed-onset soreness effect size 0.45.
Meta-analysis Network meta-analysis on optimal wavelength of low-level laser therapy in knee osteoarthritis (2024) 13 RCTs, 673 people. Pain effect size 0.96 (0.31 to 1.61). 904 to 905 nm ranked highest. Certainty low to very low.
Meta-analysis Photobiomodulation in burn wounds: systematic review and meta-analysis (2025) Null for burn-wound retraction (SMD -0.22) and collagen deposition (SMD -0.02).
Mechanistic Mitochondrial mechanisms of photobiomodulation in context of new data about multiple roles of ATP (2010) Identifies cytochrome c oxidase as the photoacceptor. The mechanistic foundation of the whole modality.
Review Mechanisms and applications of the anti-inflammatory effects of photobiomodulation (2017) Cytochrome c oxidase activation, NF-kB modulation and reactive-oxygen-species hormesis.
Review Photobiomodulation as medicine: low-level laser therapy for acute tissue injury or sport performance recovery (2024) Promising for surface wound healing and localised exercise recovery. Less convincing for acute deep-tissue injury.
Trial Significant improvements in cognitive performance post-transcranial red and near-infrared LED treatments in chronic mild TBI (2011) Open-label pilot. Cognitive improvements with transcranial photobiomodulation.
Guideline WALT dosage recommendations (2010) International low-level laser therapy dosing standards by indication.

Glossary

Quick reference for the medical and technical terms used in this comparison.

ATA Atmospheres Absolute: The pressure unit for hyperbaric chambers. The evidence base sits at 2.0 to 2.4 ATA; home soft chambers reach only 1.3 to 1.5.
HBOT Hyperbaric Oxygen Therapy: Breathing near-100% oxygen at raised pressure, so far more oxygen dissolves in plasma than haemoglobin can carry.
PBM Photobiomodulation: The technical name for red light therapy. Red and near-infrared photons absorbed by mitochondrial enzymes to change cell signaling.
CCO Cytochrome c Oxidase: Complex IV of the mitochondrial electron transport chain, and the photoacceptor Karu 2010 identified as red light's primary target.
HIF-1a Hypoxia-Inducible Factor 1-alpha: The oxygen-sensing transcription factor HBOT triggers through the repeated hyperoxia-then-normoxia swing, driving angiogenesis.
VEGF Vascular Endothelial Growth Factor: The new-blood-vessel signal. The single target both interventions share, arrived at by completely different routes.
UHMS Undersea and Hyperbaric Medical Society: The body that maintains the list of accepted clinical indications for HBOT. If your reason is not on it, you are off-label.
WALT World Association for Laser Therapy: Publishes dose recommendations by indication for low-level laser and LED therapy. The closest thing red light has to a reference dose.
DOMS Delayed Onset Muscle Soreness: Post-exercise soreness peaking a day or two after training. Leal-Junior 2015 found a 0.45 effect size for red light here.

Nick Urban Health Optimization Researcher & CHEK Holistic Lifestyle Coach Level 2

I use red light therapy daily and rate it 8.5, treating it like flossing: short sessions, consistent frequency, for years rather than weeks

Reviewed Sep 8, 2026 · next review Dec 7, 2026

Find which one fits your biology

Take the BioHarmony Quiz